Cervical cancer is one of the gynecologic cancers.
Gynecologic cancers arise in the tissues or organs of the female reproductive tract. The specific gynecologic cancer type is generally named after the organ where it originates.
Each year, approximately 80,000 women are diagnosed with one of these types with a majority of gynecologic cancers classified as either ovarian or uterine.
Cervical cancer affects the cervix – the passage between the uterus and the vagina.
With the use of the Pap smear as an early screening tool, abnormal tissue development can often be found at an early stage.
The human papilloma virus (HPV) is linked to the development of cervical cancer and a vaccine has been introduced as a weapon to prevent this disease.
Currently, oncologists base their treatment strategies upon the stage of disease.
Early stage may be managed with surgery alone. For more advanced stages, physicians generally use standard chemotherapy protocols.
For cervical cancer patients it is usually cisplatin often combined with radiation.
Nagourney Cancer Institute tests each patient's tumor to determine the right drug or drugs to prescribe for a woman with cervical cancer.
Our clinical staff works with each patient to provide an individualized and comprehensive treatment plan.
Call us today at 1-800-542-4357 or contact us via email HERE. to see how the Nagourney Cancer Institute can help you identify the most effective cervical cancer treatment based on your unique tumor makeup.
I had an extremely aggressive form of advanced ovarian cancer and my life expectancy was measured in weeks to months. Today, I am cancer free. When all other physicians wrote me off for dead, Dr. Robert Nagourney gave me life.
— Elizabeth Panke
This time the tests revealed that Marjorie had Stage IV ovarian cancer. And as is typical with this diagnosis, she was given about one year to live. But instead of listening to her own doctor, she listened to the advice of Ronald Bitter, MD, Neena’s doctor, who referred her to Robert Nagourney, MD, and Rational Therapeutics (now Nagourney Cancer Institute).
— Marjorie Gromme